HIGH QUALITY SERVICE

high technology innovation , high speed development.

HIGH QUALITY SERVICE

動物低氧實驗系統(XL) OX-100
 

塔望科技提供全系列的動物實驗用低/高氧控制產品,包括恆定濃度控制的低氧動物箱、高氧動物箱、可編程的間歇氧濃度控制系統、帶緩衝艙的手套低氧箱等。整套低氧/高氧實驗箱裝置主要由氧氣控制器和動物實驗箱兩部分組成。另可提供多種不同的氣體控制器,滿足不同實驗O 2、CO 2、NO、CO、O 3等氣體濃度控制的需求。

 

Ox-100動物低氧實驗系統可以控制動物實驗箱內持續低氧的環境,用來製造相關的低氧實驗模型。使用者可自由設定所需的濃度和實驗持續時間,所有的設定透過控制主機觸控螢幕完成,人性化設計,操作簡單。

 

Ox-100動物低氧實驗系統監測指標全面,動物低氧艙內有整合的感測器模組,內建溫度、濕度、氧氣、二氧化碳感測器。可即時監測動物低氧艙內的環境。系統透過閉環回饋控制,根據動物低氧艙內的氧濃度即時回饋控制,使動物實驗低氧數據更準確,避免了控制型濃度輸出和低氧艙內濃度不一致的情況。 Ox-100動物低氧實驗系統具有優良的控制性能,持續低氧實驗時,氧濃度的誤差為0.1%。

 

Ox-100動物低氧實驗系統提供不同尺寸的動物低氧箱,預設低氧箱可放置1個大鼠籠(或2個小鼠籠),同時提供大規格,可容納2個大鼠籠和4個大鼠籠。如需其它規格,可提供客製化。

 

如需高氧實驗,請選擇型號Ox-100HE。

產品特點及參數

1. 為動物低氧實驗模型的建立提供穩定的低氧環境

 

2. 依照設定氣體濃度自動配比氣體,維持恆定的氧氣濃度環境。無需在箱體外混合比例氣體,實驗氧濃度的準確,節省氣源

 

3. 艙體採用全透明PMMA材質,防止因光線影響動物生物節律

 

4. 7吋大螢幕觸控螢幕控制,人性化介面,操作簡單

 

5. 監測參數:溫度、濕度、氧氣O2濃度、二氧化碳濃度

 

6. 控制精度:±0.1%

 

7. 非色散紅外線(NDIR)二氧化碳感測器,測量範圍:0~5000ppm

 

8. 進口電化學氧氣O 2濃度偵測器,測量範圍:0-25%vol,線性度好,偵測準確、使用壽命長。具有溫度補償機制

 

9. 溫度偵測:進口高精度溫度感測器

 

10. 氧氣濃度變化動態曲線,直覺了解氧氣濃度變化的過程

 

11. 具有定時功能,實驗完成,自動恢復常氧狀態,並伴隨聲音提示

 

12. 氧氣濃度自動校準:透過控制器對感測器快速校準

 

13. 特有的氣體混合及循環機制,確保箱體內氣體濃度的均一

 

14. 高性能電磁閥,性能穩定,超長壽命

 

15. 艙體尺寸有多種選擇,可靈活搭配。也可依實驗要求進行客製化


應用領域

肺動脈高壓、腎臟疾病研究、腫瘤研究、心血管疾病研究、視網膜病變、運動醫學研究、OSAHS、腦部發育與神經生物學、幹細胞研究、醫學研究等

型號說明


艙體型號(可選擇不同尺寸的低氧艙)


相關文獻

[1] Drekolia MK, Mettner J, Wang D, et al. Cystine import and oxidative catabolism fuel vascular growth and repair via nutrient-responsive histone acetylation[J]. Cell Metabolism (IF 30.9), 2025.

 

[2] Wu LW, Chen M, Jiang CY, et al. Inactivation of AXL in Cardiac Fibroblasts Alleviates Right Ventricular Remodeling in Pulmonary Hypertension[J]. Advanced Science (IF 14.1), 2025: e08995.

 

[3] Lei R, Gu M, Li J, et al. Lipoic acid/trometamol assembled hydrogel as injectable bandage for hypoxic wound healing at high altitude[J]. Chemical Engineering Journal (IF 13.4), 2024, 149: 1549: 11.

 

[4] Li Z, Li H, Qiao W, et al. Multi-omics dissection of high TWAS-active endothelial pathogenesis in pulmonary arterial hypertension: bridging single-cell heterogeneity, machine learning-driven biomarkers, and 00,006 月, 1. 10.1097.

 

[5] Pei Y, Huang L, Wang T, et al. Bone marrow mesenchymal stem cells loaded into hydrogel/nanofiber composite scaffolds ameliorate ischemic brain injury[J]. Materials Today Advances (IF 10), 2023, 1749.

 

[6] Wang Q, Liu J, Li

 

[7] Wang Y, Zhang R, Chen Q, et al. PPARγ Agonist Pioglitazone Prevents Hypoxia-induced Cardiac Dysfunction by Reprogramming Glucose Metabolism[J]. International Journal of Biological Sciences, 2024, 20(11): 4297.

 

[8] Wang Y, Shen P, Wu Z, et al. Plasma Proteomic Profiling Reveals ITGA2B as a key regulator of heart health in high-altitude settlers[J]. Genomics, Proteomics & Bioinformatics, 2025: qzaf030.

 

[9] Lan Y, Zhao S, Song Y, et al. Physicochemical properties of selenized quinoa protein hydrolysate and its regulatory effects on neuroinflammation and gut microbiota in hypoxic mice[J]. Journal of Future Foods, 2025.

 

[10] Pan Z, Yao Y, Liu X, et al. Nr1d1 inhibition mitigates intermittent hypoxia-induced pulmonary hypertension via Dusp1-mediated Erk1/2 deactivation and mitochondrial fission attenuation[J].D.

 

[11] Zhou Y, Ni Z, Liu J, et al. Gut Microbiota‐Associated Metabolites Affected the Susceptibility to Heart Health Abnormality in Young Migrants at High‐Altitude: Gut Microbiota and Associated Metabolites Impart Health Heart inloration Impart Health Heart in202/125025025025325025325025023250250232502502532502503250253250250325025325025039

 

[12] Li C, Zhao Z, Jin J, et al. NLRP3-GSDMD-dependent IL-1β Secretion from Microglia Mediates Learning and Memory Impairment in a Chronic Intermittent Hypoxia-induced Mouse Model[J]. Neuroscience, 2024, 539: 5.

 

[13] Yang W, Li M, Ding J, et al. High-altitude hypoxia exposure inhibits erythrophagocytosis by inducing macrophage ferroptosis in the spleen[J]. Elife, 2024, 12: RP87496.

 

[14] You Z, Huang Q, Zeng L, et al. Rab26 promotes hypoxia-induced hyperproliferation of PASMCs by modulating the AT1R-STAT3-YAP axis[J]. Cellular and Molecular Life Sciences, 2025, 82(1): 1]. Cellular and Molecular Life Sciences, 2025, 82(1): 1-16.

 

[15] Pei C, Shen Z, Wu Y, et al. Eleutheroside B Pretreatment Attenuates Hypobaric Hypoxia‐Induced High‐Altitude Pulmonary Edema by Regulating Autophagic Flux via the AMPK/mTOR Pathway[J Research. Phytway, 120124). 5657-5671.

 

[16] Duan H, Han Y, Zhang H, et al. Eleutheroside B Ameliorates Cardiomyocytes Necroptosis in High-Altitude-Induced Myocardial Injury via Nrf2/HO-1 Signaling Pathway[J]. Antioxidants, 2025, 1402).

 

[17] Song J, Zheng J, Li Z, et al. Sulfur dioxide inhibits mast cell degranulation by sulphenylation of galectin-9 at cysteine 74[J]. Frontiers in Immunology, 2024, 15: 1369326.

 

[18] Jia N, Shen Z, Zhao S, et al. Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr. etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflamma-15 Immunopharmacology, 2023, 121: 110423.

 

[19] Huang Q, Han X, Li J, et al. Intranasal Administration of Acetaminophen-Loaded Poly (lactic-co-glycolic acid) Nanoparticles Increases Pain Threshold in Mice Rapidly Entering High Altitudes[J]. Pharmaceses Pain Threshold in Mice Rapidly Entering High Altitudes[J]. Pharmaceutics, 2025, 31355: 34135):

 

[20] Wu Y, Tang Z, Du S, et al. Oral quercetin nanoparticles in hydrogel microspheres alleviate high-altitude sleep disturbance based on the gut-brain axis[J]. International Journal of Pharmaceutics, 2024, gut-brain axis[J]. International Journal of Pharmaceutics, 2024, gut-bra8: 26425.

 

[21] Zhou Z, Zhao Q, Huang Y, et al. Berberine ameliorates chronic intermittent hypoxia‐induced cardiac remodelling by preserving mitochondrial function, role of SIRT6 signalling[J]. Journal of Cellular and Molecc.

 

[22] Shang W, Huang Y, Xu Z, et al. The impact of a high-carbohydrate diet on the cognitive behavior of mice in a low-pressure, low-oxygen environment[J]. Food & Function, 2025, low-oxygen environment[J]. Food & Function, 2025, 16(3): 11119.

 

[23] Pei C, Jia N, Wang Y, et al. Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1/2-P90rsk-BAD Jaling pathway[] 176065.

 

[24] Xie L, Wu Q, Huang H, et al. Neuroregulation of histamine of circadian rhythm disorder induced by chronic intermittent hypoxia[J]. European Journal of Pharmacology, 2025: 177662.

 

[25] Ding Y, Liu W, Zhang X, et al. Bicarbonate-Rich Mineral Water Mitigates Hypoxia-Induced Osteoporosis in Mice via Gut Microbiota and Metabolic Pathway Regulation[J]. Nutrients, 2025, 17(6): 998.

 

[26] Gu N, Shen Y, He Y, et al. Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay[J]. Journal of Molecular and Cellular Cardiology, 2024.

 

[27] Luan X, Zhu D, Hao Y, et al. Qibai Pingfei Capsule ameliorated inflammation in chronic obstructive pulmonary disease (COPD) via HIF-1 α/glycolysis pathway mediated of BMAL1[J]. International Immunopharmacology, 2025, 144: 113636.

 

[28] Jiang H, Lu C, Wu H, et al. Decreased cold‐inducible RNA‐binding protein (CIRP) binding to GluRl on neuronal membranes mediates memory impairment resulting from prolonged hypobaric hypoxia exptes memory impairment resulting from prolonged hypobaric hypoxia expgscience, 5045,005,0005,0005, 00205,0205,0005; 30(9): e70059.

 

[29] Chang P, Xu M, Zhu J, et al. Pharmacological Inhibition of Mitochondrial Division Attenuates Simulated High‐Altitude Exposure‐Induced Memory Impairment in Mice: [30] Involvement of InhibitionInduced Memory Impairment in Mice: [30] Involvement of Inhibition ofMedirat, n合適. 2025, 31(6): e70473.

 

[30] Liu C, Qu D, Li C, et al. miR‐448‐3p/miR‐1264‐3p Participates in Intermittent Hypoxic Response in Hippocampus by Regulating Fam76b/hnRNPA2B1[J] TheC Rippocampus by Regulating Fam76b/hnRNPA2B1[J] TheC​​Ticx & e70239.

 

[31] Wu LW, Chen M, Jiang DJ, et al. TCF7 enhances pulmonary hypertension by boosting stressed natural killer cells and their interaction with pulmonary arterial smooth muscle cells[J]. Respiratory Research, 2025, 2025): 2025): 2025.

 

[32] Xie L, Wu Q, Huang H, et al. Neuroregulation of histamine of circadian rhythm disorder induced by chronic intermittent hypoxia[J]. European Journal of Pharmacology, 2025: 177662.

 

[33] Cai S, Li Z, Bai J, et al. Optimized oxygen therapy improves sleep deprivation-induced cardiac dysfunction through gut microbiota[J]. Frontiers in Cellular and Infection Microbiology, 2025, 15: 1522431.

 

[34] Wang X, Xie Y, Niu Y, et al. CX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting[J]. Frontiers in Cellular Neuroscience, 2023, 17: 119348.

 

[35] He Y, Wang Y, Duan H, et al. Pharmacological targeting of ferroptosis in hypoxia-induced pulmonary edema: therapeutic potential of ginsenoside Rg3 through activation of the PI3K/AKT pathway[J]. Frontiers in through activation of the PI3K/AKT pathway[J]. Frontiers in through activation of the PI3K/AKT pathway[J]。

 

[36] Guo Y, Qin J, Sun R, et al. Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice[J]. Biological Research, 2024, 57.

 

[37] Liu L, Zhang J, Song S, et al. Paraventricular nucleus neurons: important regulators of respiratory movement in mice with chronic intermittent hypoxia[J]. Annals of Medicine, 2025, 57(1): 2588864.

 

[38] Ma Q, Ma J, Cui J, et al. Oxygen enrichment protects against intestinal damage and gut microbiota disturbance in rats exposed to acute high-altitude hypoxia[J]. Frontiers in Microbiology, 2023, 14.

 

[39] Lan J, Lin J, Guo Y, et al. Sequencing and bioinformatics analysis of exosome-derived miRNAs in mouse models of pancreatic injury induced by OSA[J]. Frontiers in Physiology, 2025, 164: 1.

 

[40] Feng X, Li C, Zhang W, et al. Mechanism of retinal angiogenesis induced by HIF-1α and HIF-2α under hyperoxic conditions[J]. Scientific Reports, 2025, 15(1): 36049.

 

[41] Yao Y, Chen Y, Li Y, et al. TGM2 Enhances Hypobaric Hypoxia-mediated Brain Injury Via Regulating NLRP3/GSDMD Signaling[J]. Neurochemical Research, 2025, 50(6): 1-11.

 

[42] Yang A, Guo L, Zhang Y, et al. MFN2-mediated mitochondrial fusion facilitates acute hypobaric hypoxia-induced cardiac dysfunction by increasing glucose catabolism and ROS production[J].SGeneica, etc​​an (Badjica, Subduction[J.3m), 2030mica (Badjica, Subduction[J33mica, 203) (BGeneica), Subduction[J33mica (BGeneica), 20mica (BGeneica), 20mica) 130413.

 

[43] Chu H, Jiang W, Zuo N, et al. Astrocyte activation: A key mediator underlying chronic intermittent hypoxia-induced cognitive dysfunction[J]. Sleep Medicine, 2025: 106692.

 

[44] Xu A, Huang F, Chen E, et al. Hyperbaric oxygen therapy attenuates heatstroke-induced hippocampal injury by inhibiting microglial pyroptosis[J]. International Journal of Hyperthermia, 2024, 41(1):2382162.3821

 

[45] Zhang Z, Zheng X, He Y, et al. Hyperbaric oxygen ameliorates neuroinflammation in heat-stressed BV-2 microglial cells: potential involvement of EAAT2 regulation[J]. International Journal of Hyperthermia, 2025, EAAT2 regulation[J]. International Journal of Hyperthermia, 2025, 48325252525252